Sir Michael George Parke Stoker: A virology pioneer  by Crawford, Lionel
In Memoriam
Sir Michael George Parke Stoker: A virology pioneer
A drawing of Sir Michael Stoker as President of Clare Hall, done
by BobTulloch. (Reprinted with permission of the artist.)
Sir Michael George Parke Stoker died on August 13th 2013. He
was a modest man, never insisting on his title being used; indeed
he insisted on it not being used on the nameplate of the ﬂat in
Cambridge where he lived for some years after his retirement. In
contrast his inﬂuence on the development of virology was far from
modest. In his quiet, friendly way he made a huge contribution to
the whole area of virology and cell biology, both in the UK and
much further aﬁeld. He was interested in the impact of virus
infection on cells, initially with lytic viruses like herpes and later
with the much more subtle interactions of tumor viruses leading
to transformation and tumors. This took him into all the complex
ways that cells communicate with each other, cell motility,
cytokines, cell biology and molecular biology. The width of his
knowledge and interests was astonishing and his circle of friends
was worldwide, encompassing all branches of biological science
and far beyond.
His family background was in medicine and, after qualifying in
medicine in Cambridge, he served in the RAMC in India and
elsewhere. He had to deal with all sorts of tropical diseases,
including typhus, in the ﬁeld and in the laboratory. This was the
beginning of his interest in Rickettsia and viruses. After his
demobilization he returned to Cambridge as lecturer in Pathology,
fellow of Clare College and Director of Medical Studies. Although
his lab in Pathology was not exactly high tech, the period from
1949 to 1959 was a very important and exciting time for the
biological sciences and for him. Molecular biology and cell biology
were developing rapidly, James Watson and Francis Crick were
working in the Cavendish lab on the other side of Downing street
and Michael became friendly with them and with the group
working on nucleic acids at the Molteno Institute. Also in the
Cavendish, electron microscopy was making it possible to see the
viruses on which he was working and details of their structure.
Virology had still not become a respectable subject in its own right
but virus research was going on in pathology, microbiology and a
whole variety of other departments, although generally it was
considered a bit of an oddity.
That all changed when Michael became the ﬁrst Professor of
Virology in UK in Glasgow University in 1959. After a (fortunately)
brief spell in temporary quarters in Anderson College he was able
to move to the new, purpose built, Institute of Virology. Here
Michael set up a well-resourced lab with large scale tissue culture,
electron microscopy and all the facilities needed to move virology
to the next level. In the next nine years it became a major center
with an international reputation. With Ian, Michael isolated the
ﬁrst quasi-normal hamster cell line that could be grown in bulk
(Stoker and Macpherson, 1964). This could be transformed with
polyoma virus to produce tumors in hamsters, thus allowing direct
comparison between normal cells and the tumorigenic cells
derived from them (Stoker, 1964, 1968; Stoker and Abel, 1962).
The cells were important not only for transformation but also for
large scale virus production and were used to produce the ﬁrst
foot and mouth disease virus vaccine.
In the Institute, research groups had a great deal of indepen-
dence and were encouraged to collaborate with other groups both
within the Institute and outside. A big advantage of locating the
Institute in Glasgow was the number of active groups nearby. At
the Vet School Bill Jarret's group was working on bovine papilloma
virus and later isolated feline leukemia virus, producing a success-
ful vaccine against it. The Professor of Genetics was Guido
Pontecorvo (Ponte) who became a next door neighbor to the
Institute and a good friend of Michael's. To keep everyone up to
date with work elsewhere we had a Journal Club and research
seminars where everyone was expected to present their work and
were duly grilled on ‘Why’ and asked ‘Why not try…?’ With a
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constant stream of visitors coming through and talking about their
work it was a very stimulating place to be. Apart from under-
graduate teaching in the university, workshops were set up for
people from outside the Institute who were just getting into
virology and cell biology, so that they could pick up the basic
techniques to help them get going. As a result of all this, it seemed
later on that most of the major virology appointments in the UK
were people who had been in Glasgow and worked in the lab, or
visited the lab, or been on one of the workshops at some time. The
standards that he set and the approach to science they learned in
Glasgow carried on Michael's inﬂuence in all these places.
Tumor viruses had by now become a major part of cancer
research and in 1968 Michael moved to London as Director of
Research at the ICRF (now part of Cancer Research UK). Over the
next 10 years Michael transformed and enlarged ICRF greatly
increasing its scope and making changes that he had found so
useful in Glasgow, introducing an emphasis on cell biology and
molecular biology and bringing in genetics. Guido Pontecorvo,
Michael's friend and neighbor from Glasgow, came to London to
have his own lab at ICRF when he retired, insisting that it was kept
small—an example Michael followed later. Not all the changes
introduced at ICRF were popular. Insisting that all the research
staff gave seminars to explain what they were doing, and why,
seemed like a bit of an intrusion to some. But the changes were
very effective, as can be seen in “A history of ICRF” Chapter 9, “The
creation of a center of excellence” (Austoker, 1988). A later
innovation was the creation of an Academic Board, to which senior
members were elected by the research staff as a whole. One of
these was Paul Nurse, who later became Director of Research at
ICRF. In 1978, Michael handed over the Directorship of ICRF to Sir
Walter Bodmer, but he did not really retire, keeping his own small
lab where he could continue to work on cell motility and scatter
factor hands-on (e.g., (Stoker et al., 1987; Stoker, 1972)), something
he really enjoyed through his entire career. Apart from the insights
this produced, it also kept him in touch with the practicalities of
setting up and carrying out experiments, making him a much
more sympathetic mentor for students and staff alike in his labs
and elsewhere. His expertise was also much in demand as Chair of
the UK Coordinating Committee for Cancer Research, at the Royal
Society as Foreign Secretary, at Strangeways Research Laboratories,
at the Ludwig Institute, and with the biotechnology company
Celltech and elsewhere. He not only wanted to understand the
inner workings of cells and how they interacted with each other
but wanted all the science involved in cancer research to be
understood much more widely by the general public. So in the
1990s he was invited back to ICRF to teach the graduate students
how to communicate science, something he was always good at.
The papers from Michael's labs do not, in many cases, have his
name on them. Only if he had contributed signiﬁcantly to the work
hands-on did he feel that he should be an author. But now I can
hear him telling me that I have missed out the most important
element in his life—people. His wife, Veronica (nee English) and
their three sons and two daughters were very important to him.
Michael and Veronica were happily married for 62 years, initially
seeing little of each other during the war. The support she gave
him, through all the house moves they endured and all
the appointments he held, was central to Michael's life. She
entertained Nobel Prize winners and foreign dignitaries alike,
members of his lab and members of his college. When he was
President of Clare Hall in Cambridge every member of the college
was invited to dinner at some time during their year in college.
The other people he would want to be acknowledged certainly
include Bill House, his laboratory manager and right hand man,
someone he could rely on to get things done. He spent time in
Renato Dulbecco's lab at the Salk Institute and Renato came to
ICRF for four years. During this time Renato was awarded his Nobel
Prize but, typically, Michael made clear when he spoke about it,
that it was awarded for work that was done before Renato came to
ICRF. It was also the time when the ﬁrst Clinical Research Fellows
were appointed in ICRF, bringing in medically qualiﬁed people to
do Ph. D.'s in the lab. The idea was to bridge the gap between
clinical research and the lab bench and the scheme did meet with
some success. When John Cairns left Cold Spring Harbor Labora-
tory to become Director of the ICRF Mill Hill lab, he became an
important part of the fund's involvement in cancer epidemiology.
The way in which Michael drew talented people to ICRF was
remarkable and when things turned out well, as they often did, he
would always give credit to the people in the labs he ran, rather
than taking credit himself. But he must take the credit for having
the foresight to appoint them, often when quite young, giving
them their independence and a lot of support and encouragement
as they became established. Many people now running very
successful labs all over the world got their start in his lab(s). For
myself I am extremely grateful for the start he gave me, the
conﬁdence he had in me and for his trust and friendship over the
many years I spent in Glasgow, London and Cambridge. His death
marks the end of an era.
Throughout his career Michael was an enthusiastic sailor and a
very talented artist. It was sometimes difﬁcult to get him to part
with his paintings, although he did give several away. One I was
pleased to ﬁnd, and buy, was at an exhibition and sale in aid of the
President's Fund at Clare Hall, but I was puzzled by the odd price.
It turned out to be just the cost of the frame.
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